BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

620 related articles for article (PubMed ID: 28258053)

  • 21. The predictive ability of serum alpha-fetoprotein for hepatocellular carcinoma is linked with the characteristics of the target population at surveillance.
    Huo TI; Hsia CY; Chu CJ; Huang YH; Lui WY; Wu JC; Lee PC; Chi CW; Lee SD
    J Surg Oncol; 2007 Jun; 95(8):645-51. PubMed ID: 17530668
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Usefulness of serum alpha-fetoprotein (AFP) as a marker for hepatocellular carcinoma (HCC) in hepatitis C virus related cirrhosis: analysis of the factors influencing AFP elevation without HCC development].
    Kim KA; Lee JS; Jung ES; Kim JY; Bae WK; Kim NH; Moon YS
    Korean J Gastroenterol; 2006 Nov; 48(5):321-6. PubMed ID: 17132920
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparing the diagnostic value of serum oligosaccharide chain (G-test) and alpha-fetoprotein for hepatitis B virus-related liver cancer.
    Wan L; Guo L; Hu Y; Huang H; Zhang M; Xu K; De G; Zheng F; Wu Z; Hu C; Wen Z
    Clin Biochem; 2021 Mar; 89():44-50. PubMed ID: 33309517
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Serum anti-Ku86: a potential biomarker for early detection of hepatocellular carcinoma].
    Chu L; Zhang X; Wang G; Zhou W; Du Z; Liu A; Zhao H
    Zhonghua Zhong Liu Za Zhi; 2014 Feb; 36(2):123-7. PubMed ID: 24796461
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Performance of Serum Alpha-Fetoprotein for Detecting Early-Stage Hepatocellular Carcinoma Is Influenced by Antiviral Therapy and Serum Aspartate Aminotransferase: A Study in a Large Cohort of Hepatitis B Virus-Infected Patients.
    Qian X; Liu Y; Wu F; Zhang S; Gong J; Nan Y; Hu B; Chen J; Zhao J; Chen X; Pan W; Dang S; Lu F
    Viruses; 2022 Jul; 14(8):. PubMed ID: 36016291
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Significance of Glypican-3 in Early Detection of Hepatocellular Carcinoma in Cirrhotic Patients.
    Tahon AM; El-Ghanam MZ; Zaky S; Emran TM; Bersy AM; El-Raey F; A Z E; El Kharsawy AM; Johar D
    J Gastrointest Cancer; 2019 Sep; 50(3):434-441. PubMed ID: 29623600
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early detection of hepatocellular carcinoma co-occurring with hepatitis C virus infection: A mathematical model.
    Zekri AR; Youssef AS; Bakr YM; Gabr RM; Ahmed OS; Elberry MH; Mayla AM; Abouelhoda M; Bahnassy AA
    World J Gastroenterol; 2016 Apr; 22(16):4168-82. PubMed ID: 27122667
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic utility of alpha-fetoprotein and des-gamma-carboxyprothrombin in nigerians with hepatocellular carcinoma.
    Ette AI; Ndububa DA; Adekanle O; Ekrikpo U
    Niger J Clin Pract; 2017 Oct; 20(10):1267-1272. PubMed ID: 29192630
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alpha-fetoprotein to transaminase ratio is related to higher diagnostic efficacy for hepatocellular carcinoma.
    Liu X; Meng J; Xu H; Niu J
    Medicine (Baltimore); 2019 Apr; 98(17):e15414. PubMed ID: 31027143
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of Alanine Transaminase Levels on Alpha-Fetoprotein for Predicting Hepatocellular Carcinoma in Patients with Hepatitis B Infection.
    Chen J; Wu M; Gong J; Liu Z; He G; Zhu H; Li Z; Hu B
    Biomed Res Int; 2020; 2020():2043715. PubMed ID: 33490235
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors that affect accuracy of α-fetoprotein test in detection of hepatocellular carcinoma in patients with cirrhosis.
    Gopal P; Yopp AC; Waljee AK; Chiang J; Nehra M; Kandunoori P; Singal AG
    Clin Gastroenterol Hepatol; 2014 May; 12(5):870-7. PubMed ID: 24095974
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic value of gamma-glutamyl transpeptidase to alkaline phosphatase ratio combined with gamma-glutamyl transpeptidase to aspartate aminotransferase ratio and alanine aminotransferase to aspartate aminotransferase ratio in alpha-fetoprotein-negative hepatocellular carcinoma.
    Li J; Tao H; Zhang E; Huang Z
    Cancer Med; 2021 Jul; 10(14):4844-4854. PubMed ID: 34145988
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development and Internal Validation of a Model for Early Detection of Hepatocellular Carcinoma in Patients With Cirrhosis.
    Patel J; Yopp A; Waljee AK; Singal AG
    J Clin Gastroenterol; 2016 Feb; 50(2):175-9. PubMed ID: 26125462
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum VEGF as a tumor marker in patients with HCV-related liver cirrhosis and hepatocellular carcinoma.
    Mukozu T; Nagai H; Matsui D; Kanekawa T; Sumino Y
    Anticancer Res; 2013 Mar; 33(3):1013-21. PubMed ID: 23482775
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transient elastography for the detection of hepatocellular carcinoma in viral C liver cirrhosis. Is there something else than increased liver stiffness?
    Feier D; Lupsor Platon M; Stefanescu H; Badea R
    J Gastrointestin Liver Dis; 2013 Sep; 22(3):283-9. PubMed ID: 24078985
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum biomarkers for early detection of hepatocellular carcinoma associated with HCV infection in egyptian patients.
    Zekri AR; Youssef AS; Bakr YM; Gabr RM; El-Rouby MN; Hammad I; Ahmed EA; Marzouk HA; Nabil MM; Hamed HA; Aly YH; Zachariah KS; Esmat G
    Asian Pac J Cancer Prev; 2015; 16(3):1281-7. PubMed ID: 25735368
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alpha-fetoprotein still is a valuable diagnostic and prognosis predicting biomarker in hepatitis B virus infection-related hepatocellular carcinoma.
    Yao M; Zhao J; Lu F
    Oncotarget; 2016 Jan; 7(4):3702-8. PubMed ID: 26784252
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum alpha-fetoprotein may have a significant role in the surveillance of hepatocellular carcinoma in hepatitis B endemic areas.
    Sinn DH; Yi J; Choi MS; Kim YJ; Gwak GY; Lee JH; Koh KC; Paik SW; Yoo BC
    Hepatogastroenterology; 2015; 62(138):327-32. PubMed ID: 25916058
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liver Cancer-Specific Serine Protease Inhibitor Kazal Is a Potentially Novel Biomarker for the Early Detection of Hepatocellular Carcinoma.
    Lu F; Shah PA; Rao A; Gifford-Hollingsworth C; Chen A; Trey G; Soryal M; Talat A; Aslam A; Nasir B; Choudhry S; Ishtiaq R; Sanoff H; Conteh LF; Noonan A; Hu KQ; Schmidt C; Fu M; Civan J; Xiao G; Lau DT; Lu X
    Clin Transl Gastroenterol; 2020 Dec; 11(12):e00271. PubMed ID: 33512798
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Natural history of chronic hepatitis B REVEALed.
    Chen CJ; Yang HI
    J Gastroenterol Hepatol; 2011 Apr; 26(4):628-38. PubMed ID: 21323729
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.